The Migraine Relief Center Blog

Here’s the latest from the Migraine Relief Center

Keep up with the doctors, patients, treatments—and results—from all our locations.

How Migraineurs Can Work From Home with Less Pain

By Migraine Relief Center on April 22, 2020

Working from home can seem like the perfect solution for a migraineur. When a migraine strikes, you are already in an environment where you have ready access to dark rooms and medication. However, if working from home is not a normal part of your routine, you may feel more stressed than usual.

Read More

Why Is Headache Misdiagnosed In Women?

By Migraine Relief Center on December 31, 2019

The misdiagnosis of migraine is common. Around half of people presenting with headache pain are not diagnosed correctly as to its cause. So, there is already an issue present that can become more challenging for women.

Read More

A Review: Three Studies of the Effects of Cannabis on Migraines

By Migraine Relief Center on December 9, 2019

While the popularity of cannabidiol (CBD) continues to soar, there are still few studies available with data to support its use. Now that industrial hemp farming is legal, studies of hemp oil and CBD on migraines may become more available. Confounding some of the efforts is the fact that, while CBD is legal at the federal level, it is still illegal in some states. However, the trend appears to be toward the legalization of CBD in certain forms.

Read More

FDA Approval of Reyvow (rasmitidan) for Migraines

By Migraine Relief Center on November 11, 2019

People suffering from acute migraines will soon have another rescue medication at their disposal - The FDA approved Reyvow (lasmiditan hemisuccinate). The US Drug Enforcement Administration (DEA) has 90 days to review the drug to determine if it will be classified as a controlled substance. Once that three-month period is complete, the maker, Eli Lilly, and Company expect it to be available at retail pharmacies.

Read More

Ketamine and Migraines – A Wonder Drug?

By Migraine Relief Center on October 25, 2019

When a migraine doesn't respond to any other treatment, ketamine may offer relief. Operating differently than opioids, non-steroidal anti-inflammatories, and triptans, ketamine is increasingly available to treat chronic pain, migraine, and other health issues.

Read More

A Review of Electrical Nerve Stimulation

By Migraine Relief Center on October 11, 2019

 

Within the past decade, electrical nerve stimulation has been introduced as a potential non-drug treatment for individuals suffering migraines or cluster headaches. The approach varies slightly between techniques, and depending on the method, can be invasive or non-invasive.

Read More

Do You Have Episodic Migraines?

By Migraine Relief Center on September 30, 2019

Migraines come in several flavors, but one of the primary classifications is that of episodic migraine. Episodic migraines differ from chronic migraine disorder and may respond better to some treatments than chronic migraines.

Read More

What Are the Risks of Opioid Use for Migraineurs in This Age of Crisis?

By Migraine Relief Center on August 21, 2019

“Given the opioid epidemic in the U.S. and the high prevalence of opioid use in migraine patients shown in our study, especially those with chronic migraine, our results suggest that improved management of treatment is needed to optimize care.” - Justin S. Yu, PharmS, Allergan

Read More

A New Drug Is Approved for the Treatment of Cluster Headaches

By Migraine Relief Center on July 9, 2019

Good news for those of you who suffer from cluster headaches. On June 4,  the FDA announced it has approved Galcanezumab, sold as Emgality by Eli Lilly and Co., for the treatment of episodic cluster headaches.READY TO EXPLORE NEW MIGRAINE SOLUTIONS?    DOWNLOAD OUR FREE MIGRAINE DIARY TODAY! »

Read More

Using Oxygen Therapy To Reduce Your Migraines

By Mark Khorsandi, D.O. on February 20, 2019

Among the many physiological and environmental conditions believed to cause migraines, decreased oxygen levels and vasoconstriction of the blood flow in the brain are two of the most often cited by medical researchers.

Read More